Have you ever had a project derailed due to
How much notice do you typically receive?
Does your company have a strategy/policy
in place to address obsolescence?
Have you ever had to resubmit/revisit
an FDA submission due to obsolescence?
A few months
A year or more
34% 55% 11%
Do you maintain a relationship with a
supplier who addresses obsolescence issues?
How frequently do you encounter
Do you think there is ever a good case
for planned obsolescence?
No, it’s never okay
When it comes to certain application areas
When it concerns potential safety issues
Yes, it’s fine
Once a medical device development project moves past a certain
point, going back and making a change such as replacing a
component due to it being phased out can be costly for the OEM.
If the device has gone through regulatory review, it can add sig-
nificant time to the launch date as well. But how much does this
happen in the medtech industry, and what is being done to ad-
dress it? Those questions were asked of MDT readers in this
month’s infographic. And frankly, the responses that were re-
ceived were fairly surprising considering how significant an impact
component obsolescence can make.
designed by Eileen Whitmore, Art Director